Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of the American Society of Nephrology : JASN|February 1, 2014
Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosisBjörn Tampe, Desiree Tampe, Claudia A Müller, et al.
International Journal of Cardiology|July 23, 2014
Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney diseaseDavid M Charytan, Robert Padera, Alexander M Helfand, et al.
Cardiovascular Research|January 25, 2015
Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosisXingbo Xu, Xiaoying Tan, Björn Tampe, et al.
Nature Communications|August 31, 2018
High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosisXingbo Xu, Xiaoying Tan, Björn Tampe, et al.
Journal of the American Heart Association|February 26, 2015
Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in miceRajinikanth Gogiraju, Xingbo Xu, Magdalena L Bochenek, et al.
Clinical Epigenetics|September 11, 2023
Low levels of circulating methylated IRX3 are related to worse outcome after transcatheter aortic valve implantation in patients with severe aortic stenosisLeon Kanwischer, Xingbo Xu, Afifa Binta Saifuddin, et al.
Circulation Research|January 15, 2015
Endocardial fibroelastosis is caused by aberrant endothelial to mesenchymal transitionXingbo Xu, Ingeborg Friehs, Tachi Zhong Hu, et al.
The Journal of Clinical Investigation|April 18, 2018
Pharmacological induction of hypoxia-inducible transcription factor ARNT attenuates chronic kidney failureBjörn Tampe, Désirée Tampe, Gunsmaa Nyamsuren, et al.
Diabetology & Metabolic Syndrome|January 26, 2023
miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitusMelanie S Hulshoff, Isabel N Schellinger, Xingbo Xu, et al.
ESC Heart Failure|May 12, 2026
Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: Design and rationale of the Reduce-MFA DZHK25 trialMiriam Puls, Elisabeth M Zeisberg, Marius Placzek, et al.
Pageof 6